Vanda Pharmaceuticals VNDA
NASDAQ VNDA
$4.15 +0.07 (+1.72%)
At close: Nov 11, 2026 · 4:00 PM EST

Vanda Pharmaceuticals (VNDA) Change in Accrued Expenses (2009 - 2026)

Updated

Vanda Pharmaceuticals' Change in Accrued Expenses came in at $10.2 million for Q2 2026, down 9.9% from $11.33 million a year earlier but up 589.5% from the prior quarter.

Analysis

Vanda Pharmaceuticals (VNDA) Change in Accrued Expenses (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Vanda Pharmaceuticals reported Change in Accrued Expenses of $10.54 million, down 26.7% year-over-year; for FY2025, it came in at $15.82 million, up 826.2% from FY2024.

  • Change in Accrued Expenses carries a five-year compound annual growth rate of 33.3% (FY2020 to FY2025).
  • Going back by year, Change in Accrued Expenses was $1.71 million in FY2024, -$10.98 million in FY2023, $11.79 million in FY2022 (+287.9%) and $3.04 million in FY2021 (-19.1%).
  • The five-year range for quarterly Change in Accrued Expenses is -$10.79 million (Q1 2023) to $13.43 million (Q1 2022).
  • Year-over-year, Change in Accrued Expenses increased in two of the last four quarters, with growth averaging 140.3%.
  • Business Quant data shows VNDA's Change in Accrued Expenses at $1.48 million (Q1 2026), $9.08 million (Q4 2025) and -$10.22 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 983.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 756.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Vanda Pharmaceuticals 246.71 Mn -529.97 Mn 65.66 Mn -10.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -10.00 Mn
Jun 30, 2026 10.20 Mn
Mar 31, 2026 1.48 Mn
Dec 31, 2025 9.08 Mn
Sep 30, 2025 -10.22 Mn
Jun 30, 2025 11.33 Mn
Mar 31, 2025 5.64 Mn
Dec 31, 2024 -2.13 Mn
Sep 30, 2024 -469,000.00
Jun 30, 2024 3.14 Mn
Mar 31, 2024 1.17 Mn
Dec 31, 2023 3.33 Mn
Sep 30, 2023 -280,000.00
Jun 30, 2023 -3.24 Mn
Mar 31, 2023 -10.79 Mn
Dec 31, 2022 -3.28 Mn
Sep 30, 2022 1.34 Mn
Jun 30, 2022 306,000.00
Mar 31, 2022 13.43 Mn
Dec 31, 2021 2.18 Mn
API Access

Vanda Pharmaceuticals Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=VNDA&period=max&api_key=YOUR_API_KEY